158 related articles for article (PubMed ID: 24330255)
1. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 Mar; 21(3):454-8. PubMed ID: 24330255
[TBL] [Abstract][Full Text] [Related]
2. Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2013 Jun; 20(6):942-8. PubMed ID: 23448676
[TBL] [Abstract][Full Text] [Related]
3. Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients.
McGurgan IJ; McGuigan C
Brain Behav; 2015 Oct; 5(10):e00396. PubMed ID: 26516615
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia and risk of cancer: a population-based case-control study.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 May; 21(5):773-8. PubMed ID: 24571170
[TBL] [Abstract][Full Text] [Related]
5. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
6. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N
Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases.
van den Reek JM; van Lümig PP; Janssen M; Schers HJ; Hendriks JC; van de Kerkhof PC; Seyger MM; de Jong EM
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):27-33. PubMed ID: 23216663
[TBL] [Abstract][Full Text] [Related]
8. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.
Zhang Z; Wang M; Xu L; Jiang B; Jin T; Shi T; Xu B
J Clin Neurosci; 2021 Jun; 88():70-74. PubMed ID: 33992207
[TBL] [Abstract][Full Text] [Related]
9. Non-melanoma skin cancers and glucocorticoid therapy.
Karagas MR; Cushing GL; Greenberg ER; Mott LA; Spencer SK; Nierenberg DW
Br J Cancer; 2001 Sep; 85(5):683-6. PubMed ID: 11531252
[TBL] [Abstract][Full Text] [Related]
10. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjögren's syndrome: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Huang WC; Lu LY
Clin Exp Rheumatol; 2019; 37(6):946-952. PubMed ID: 31074727
[TBL] [Abstract][Full Text] [Related]
11. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
12. Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013.
Pedersen EG; Hallas J; Pottegård A; Hald SM; Jensen PEH; Gaist D
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):486-493. PubMed ID: 29732733
[TBL] [Abstract][Full Text] [Related]
13. [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
Braun SA; Helbig D; Frank J; Hanneken S
Hautarzt; 2012 Oct; 63(10):756-9. PubMed ID: 23008007
[TBL] [Abstract][Full Text] [Related]
14. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
Rawoot A; Little F; Heckmann JM
S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153
[No Abstract] [Full Text] [Related]
16. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?
Herrlinger U; Weller M; Dichgans J; Melms A
Ann Neurol; 2000 May; 47(5):682-3. PubMed ID: 10805346
[No Abstract] [Full Text] [Related]
17. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
18. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
Floyd A; Pedersen L; Nielsen GL; Thorlacius-Ussing O; Sorensen HT
Am J Gastroenterol; 2003 Jun; 98(6):1305-8. PubMed ID: 12818274
[TBL] [Abstract][Full Text] [Related]
19. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
20. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
Long MD; Herfarth HH; Pipkin CA; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):268-74. PubMed ID: 20005977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]